The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA
- Supplementary File 1:
PDF-Document (PDF, 256 KiB)
Chang, W.J.; Sung, J.S.; Lee, S.Y.; Kang, E.J.; Kwon, N.-J.; Kim, H.M.; Shin, S.W.; Choi, J.Y.; Choi, Y.J.; Kim, J.W.; Park, K.H.; Kim, Y.H. The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA. J. Clin. Med. 2020, 9, 2642. https://doi.org/10.3390/jcm9082642
Chang WJ, Sung JS, Lee SY, Kang EJ, Kwon N-J, Kim HM, Shin SW, Choi JY, Choi YJ, Kim JW, Park KH, Kim YH. The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA. Journal of Clinical Medicine. 2020; 9(8):2642. https://doi.org/10.3390/jcm9082642
Chicago/Turabian StyleChang, Won Jin, Jae Sook Sung, Sung Yong Lee, Eun Joo Kang, Nak-Jung Kwon, Hae Mi Kim, Sang Won Shin, Jung Yoon Choi, Yoon Ji Choi, Ju Won Kim, Kyong Hwa Park, and Yeul Hong Kim. 2020. "The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA" Journal of Clinical Medicine 9, no. 8: 2642. https://doi.org/10.3390/jcm9082642